Every week, new medical recommendations, health alerts, or regulatory changes modify the way we take care of our health. Keeping up with health news on a daily basis allows us to anticipate concrete decisions, whether it’s a vaccine to schedule, a medication under surveillance, or a seasonal risk to consider.
Vaccination Schedule 2026: Game-Changing Obligations for Infants and Young Adults
Since January 1, 2025, vaccination against meningococci ACWY and B is mandatory for infants in France. This measure replaces the previous obligation limited to meningococcus C. A transitional catch-up is planned until 2-4 years for children already vaccinated against meningococcus C.
For adolescents, ACWY meningococcal vaccination is recommended between the ages of 11 and 14, with a possible catch-up until 24 years old. This age group accounts for a significant share of invasive meningococcal infections.
The 2026 vaccination schedule also includes an extension of the HPV vaccine catch-up (Gardasil 9) until the age of 26, for both young women and young men who were not vaccinated during adolescence. This change aims to prevent cancers related to papillomavirus. To keep track of all these updates and regularly consult health news on Santé Info, it may be useful to centralize reliable medical information sources.
Vaccination for Seniors: New Recommendations After 65
Are you over 65 or do you have a loved one in this age group? The 2026 vaccination schedule strengthens the protection of this population against several respiratory infections.
Specifically, vaccination schemes are adapted to better cover the risk of complications related to seasonal flu, pneumococcus, and respiratory syncytial virus (RSV). RSV, long associated with infant bronchiolitis, also causes hospitalizations in older adults. A RSV vaccination campaign with a schedule set for 2026-2027 has been established for this population.
Vaccination prevention for seniors is no longer limited to the annual flu booster. It now includes several valences, which requires checking one’s vaccination record with a healthcare professional to identify missing doses.
Work Stoppages and Medical Control: What the September 2026 Decrees Change
Two decrees validated by the Council of State on September 9, 2026, modify the rules governing work stoppages in France. These texts, whose publication is imminent, strengthen control mechanisms.
Why does this topic directly concern daily health? Because the conditions for prescribing and extending sick leave are evolving, with consequences for the relationship between patients, treating physicians, and health insurance organizations. Several medical unions have expressed reservations about these measures, arguing that they increase administrative burdens without addressing the root causes of absenteeism.
For an employee, this means that a work stoppage could be subject to faster and more systematic control. Checking the new modalities with one’s health insurance fund becomes a useful reflex starting in the fall of 2026.
Health Alerts in France: Salmonellosis, Heat, and Arboviruses
The health news of the fall 2026 is marked by several concrete alerts that Santé publique France is closely monitoring.
- Salmonellosis linked to pumpkin seeds: 81 cases have been reported in France, leading to a product recall. Contaminated seeds can cause fever, diarrhea, and abdominal pain, with an increased risk for young children and immunocompromised individuals.
- Heat waves: France has recorded significant excess mortality until the end of July 2026. The Minister of Health announced a toll of 7,000 additional deaths related to heatwave episodes. This figure reignites the debate on adapting the healthcare system to increasingly hot summers.
- Arboviruses: diseases transmitted by mosquitoes (dengue, chikungunya) continue to progress across the territory. The 2026 vaccination schedule also includes a new chapter related to chikungunya, indicating that the threat is being taken seriously by health authorities.
What to Watch in the Coming Weeks
The weekly bulletins from Santé publique France, published for each region, allow for tracking the evolution of mortality from all causes, the circulation of respiratory viruses, and local epidemiological signals. These bulletins are available online and serve as a reference source for anticipating seasonal risks.
Medications Under Surveillance: The Case of Desogestrel and Meningiomas
The National Agency for the Safety of Medicines (ANSM) and the High Authority of Health (HAS) maintain active monitoring of several molecules. Among recent topics, the link between certain progestins, including desogestrel, and the risk of meningioma is being studied in depth.
A meningioma is a tumor, most often benign, that develops from the membranes surrounding the brain. Some medications containing progestins increase this risk when taken for long periods. This information is directly useful for patients on oral contraception or hormone therapy.
For healthcare professionals as well as for patients, regularly checking alerts from the ANSM and HAS helps identify medications subject to new restrictions or updates to their labels. These organizations publish updated recommendations accessible to the general public.
Keeping up with health news does not require becoming a medical specialist. A few reflexes are enough: consult the updated vaccination schedule each year, read alerts for food product recalls, and check regional epidemiological bulletins during seasonal peaks. These simple actions enable informed decisions for oneself and loved ones.
